Evidence map›Paper›PMID 30205137›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2018

Evaluation of androgen assay results using a curated Hershberger database.

N C Kleinstreuer, P Browne, X Chang, R Judson, W Casey, P Ceger, C Deisenroth, N Baker, K Markey, R S Thomas

Abstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Weight of evidence for cross-species conservation of androgen receptor-based biological activity.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. QuantitativeEnvironmental health perspectives · 2020
    Article
  14. Selecting a minimal set of androgen receptor assays for screening chemicals.Regulatory toxicology and pharmacology : RTP · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

N C KleinstreuerNIH/NIEHS/DNTP/NICEATM, USA. Electronic address: nicole.kleinstreuer@nih.gov.
P BrowneOECD/EHS Paris, France.
X ChangILS, RTP, NC, USA.
R JudsonEPA/ORD/NCCT, RTP, NC, USA.
W CaseyNIH/NIEHS/DNTP/NICEATM, USA.
P CegerILS, RTP, NC, USA.
C DeisenrothEPA/ORD/NCCT, RTP, NC, USA.
N BakerLeidos, RTP, NC, USA.
K MarkeyEPA/OSCP, Washington, DC, USA.
R S ThomasEPA/ORD/NCCT, RTP, NC, USA.

Funding

Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
Intramural EPA EPA999999
6 · The paper itself

Abstract

A set of 39 reference chemicals with reproducible androgen pathway effects in vivo, identified in the companion manuscript [1], were used to interrogate the performance of the ToxCast/Tox 21 androgen receptor (AR) model based on 11 high throughput assays. Cytotoxicity data and specificity confirmation assays were used to distinguish assay loss-of-function from true antagonistic signaling suppression. Overall agreement was 66% (19/29), with ten additional inconclusive chemicals. Most discrepancies were explained using in vitro to in vivo extrapolation to estimate equivalent administered doses. The AR model had 100% positive predictive value for the in vivo response, i.e. there were no false positives, and chemicals with conclusive AR model results (agonist or antagonist) were consistently positive in vivo. Considering the lack of reproducibility of the in vivo Hershberger assay, the in vitro AR model may better predict specific AR interaction and can rapidly and cost-effectively screen thousands of chemicals without using animals.

Indexed as

Biological AssayModels, BiologicalAndrogen AntagonistsAndrogensAnimalsDatabases, FactualMaleRatsReceptors, AndrogenReproducibility of ResultsAndrogen AntagonistsAndrogensReceptors, AndrogenAndrogenicAndrogen receptorAnti-androgenicEndocrine disruptorHershbergerHigh-throughput screeningIn vitroToxCast/Tox21

Identifiers

PMID30205137
PMCPMC7171594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.